These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24613412)

  • 1. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.
    Klco JM; Spencer DH; Miller CA; Griffith M; Lamprecht TL; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Fulton RS; Eades WC; Link DC; Graubert TA; Walter MJ; Mardis ER; Dipersio JF; Wilson RK; Ley TJ
    Cancer Cell; 2014 Mar; 25(3):379-92. PubMed ID: 24613412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AML salad bowl.
    Duque-Afonso J; Cleary ML
    Cancer Cell; 2014 Mar; 25(3):265-7. PubMed ID: 24651007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.
    de Boer B; Prick J; Pruis MG; Keane P; Imperato MR; Jaques J; Brouwers-Vos AZ; Hogeling SM; Woolthuis CM; Nijk MT; Diepstra A; Wandinger S; Versele M; Attar RM; Cockerill PN; Huls G; Vellenga E; Mulder AB; Bonifer C; Schuringa JJ
    Cancer Cell; 2018 Oct; 34(4):674-689.e8. PubMed ID: 30245083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
    Baron F; Stevens-Kroef M; Kicinski M; Meloni G; Muus P; Marie JP; Halkes CJM; Thomas X; Vrhovac R; Specchia G; Lefrere F; Sica S; Mancini M; Venditti A; Hagemeijer A; Becker H; Jansen JH; Amadori S; de Witte T; Willemze R; Suciu S
    Ann Hematol; 2018 Oct; 97(10):1785-1795. PubMed ID: 29926156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
    Morita K; Wang F; Jahn K; Hu T; Tanaka T; Sasaki Y; Kuipers J; Loghavi S; Wang SA; Yan Y; Furudate K; Matthews J; Little L; Gumbs C; Zhang J; Song X; Thompson E; Patel KP; Bueso-Ramos CE; DiNardo CD; Ravandi F; Jabbour E; Andreeff M; Cortes J; Bhalla K; Garcia-Manero G; Kantarjian H; Konopleva M; Nakada D; Navin N; Beerenwinkel N; Futreal PA; Takahashi K
    Nat Commun; 2020 Oct; 11(1):5327. PubMed ID: 33087716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal hierarchy of main molecular lesions in acute myeloid leukaemia.
    Herudkova Z; Culen M; Folta A; Jeziskova I; Cerna J; Loja T; Tom N; Smejkal J; Semerad L; Dvorakova D; Mayer J; Racil Z
    Br J Haematol; 2020 Aug; 190(4):562-572. PubMed ID: 31822038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of heterogeneity and evolution of subclones in t(8;21) AML by QM-FISH].
    Wang YC; Hu LP; Lin D; Li CW; Yuan T; Jia YJ; Tian Z; Tang KJ; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):844-50. PubMed ID: 24171957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
    Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
    J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukemia stem cell and clonal evolution].
    Yoshimi A; Kurokawa M
    Nihon Rinsho; 2014 Jun; 72(6):1012-7. PubMed ID: 25016797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
    Vosberg S; Greif PA
    Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
    McMahon CM; Ferng T; Canaani J; Wang ES; Morrissette JJD; Eastburn DJ; Pellegrino M; Durruthy-Durruthy R; Watt CD; Asthana S; Lasater EA; DeFilippis R; Peretz CAC; McGary LHF; Deihimi S; Logan AC; Luger SM; Shah NP; Carroll M; Smith CC; Perl AE
    Cancer Discov; 2019 Aug; 9(8):1050-1063. PubMed ID: 31088841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Evolution and Changes in Two AML Patients Detected with A Novel Single-Cell DNA Sequencing Platform.
    Xu L; Durruthy-Durruthy R; Eastburn DJ; Pellegrino M; Shah O; Meyer E; Zehnder J
    Sci Rep; 2019 Jul; 9(1):11119. PubMed ID: 31366893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution of acute leukemia genomes.
    Jan M; Majeti R
    Oncogene; 2013 Jan; 32(2):135-40. PubMed ID: 22349821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal architecture of secondary acute myeloid leukemia.
    Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
    N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML.
    Tiso F; Koorenhof-Scheele TN; Huys E; Martens JHA; de Graaf AO; van der Reijden BA; Langemeijer SMC; Preijers FWMB; Kroeze LI; Jansen JH
    Ann Hematol; 2022 Mar; 101(3):571-579. PubMed ID: 35024892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell analysis of clonal architecture in acute myeloid leukaemia.
    Potter N; Miraki-Moud F; Ermini L; Titley I; Vijayaraghavan G; Papaemmanuil E; Campbell P; Gribben J; Taussig D; Greaves M
    Leukemia; 2019 May; 33(5):1113-1123. PubMed ID: 30568172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic opportunities for medulloblastoma come of age.
    Olson JM
    Cancer Cell; 2014 Mar; 25(3):267-9. PubMed ID: 24651008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
    Kim D; Kim S; Song H; Gwak D; Min S; Byun JM; Koh Y; Hong J; Yoon SS; Yun H; Shin DY
    Cancer Med; 2024 Apr; 13(7):e7182. PubMed ID: 38591109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia.
    Paguirigan AL; Smith J; Meshinchi S; Carroll M; Maley C; Radich JP
    Sci Transl Med; 2015 Apr; 7(281):281re2. PubMed ID: 25834112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.